Cell Line Development Global Market Report 2024

Description

Cell line development involves the creation of immortalized cell cultures derived from specific cell types, often originating from a particular organism or tissue. These cell lines are nurtured under controlled laboratory conditions and can be perpetually cultivated and reproduced.

The primary product types associated with cell line development include reagents and media, equipment, accessories, and consumables. Reagents and media encompass essential components utilized in laboratory settings for diverse biological and chemical analyses, experiments, and procedures. These components are sourced from various organisms, including mammalian and non-mammalian, and are utilized to generate different types of cell lines such as recombinant, hybridomas, continuous cell lines, and primary cell lines. Applications for these cell lines span bioproduction, drug discovery, toxicity testing, tissue engineering, and research endeavors.

The cell line development market research report is one of a series of new reports from The Business Research Company that provides cell line development market statistics, including cell line development industry global market size, regional shares, competitors with a cell line development market share, detailed cell line development market segments, market trends, and opportunities, and any further data you may need to thrive in the cell line development industry. This cell line development research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell line development market size has grown rapidly in recent years. It will grow from $7.16 billion in 2023 to $8.21 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth observed during the historic period can be attributed to several factors, including increased vaccine production, a growing aging population, and an uptick in clinical trials.

The cell line development market size is expected to see rapid growth in the next few years. It will grow to $14.25 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing prevalence of cancer and chronic diseases, as well as growing government investments in healthcare. Major trends expected in the forecast period include partnerships, investments, and product innovations.

The anticipated rise in cancer prevalence is poised to drive the growth of cell line development in the foreseeable future. Cancer refers to a group of diseases characterized by the uncontrolled proliferation and spread of abnormal cells within the body. The increase in cancer cases is attributed primarily to factors such as population growth, aging, lifestyle choices, obesity, and genetic predisposition. Cell lines serve as crucial tools for screening potential drugs for their efficacy in treating chronic diseases. Researchers expose these cell lines to various compounds and observe their effects, facilitating the identification of promising drug candidates for further development. For instance, according to the World Health Organization's February 2024 report, the projected number of new cancer cases is expected to reach over 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the growing prevalence of cancer serves as a catalyst for the cell line development market.

Key players in the cell line development market are actively pursuing innovative platforms to gain a competitive advantage. These innovative platforms are distinguished by their ability to streamline and optimize the cell line development process, offering speed, efficiency, and enhanced productivity to support the development of biological drugs. For example, in January 2023, Abzena, a UK-based company providing outsourced research, development, and manufacturing services, introduced new platforms named AbZelect and AbZelectPro, designed to accelerate the cell line development (CLD) process for biologic drug programs. These platforms enhance productivity, enabling the production of greater quantities of drug substances per manufacturing run. This heightened efficiency not only expands capacity and reduces costs for customers but also expedites the delivery of critical therapies to patients in need.

In October 2022, Cytiva, a US-based life sciences company, acquired CEVEC Pharmaceuticals for an undisclosed sum. This acquisition bolsters Cytiva's capabilities in biomanufacturing solutions and supports the company's expansion in the genomic medicine sector. CEVEC Pharmaceuticals, headquartered in Germany, specializes in high-performance cell line development and viral vector manufacturing technologies.

Major companies operating in the cell line development market are Thermo Fisher Scientific Inc., Novartis AG, Danaher Corporation, Merck KGaA, GE Health Care, AGC Biologics, Corning Inc., Eurofins Scientific, Lonza Pvt. Ltd., WuXi App tech, Sartorius AG, GenScript Biotech Corporation, FUJIFILM Diosynth Biotechnologies, Promega corporation, KBI Biopharma Inc., Rentschler Biopharma SE, Advanced Instruments LLC, Cyagen, Horizon Discovery Group Plc, Probiogen AG, PromoCell GmbH, Premas Biotech, Imgenex, NAEJA RGM Pharmaceuticals Inc

North America was the largest region in the cell line development market in 2023. The regions covered in the cell line development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell line development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell line development market consists of sales of primary cell lines, immortalized cell lines, stable cell lines, and clonal cell lines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Line Development Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell line development market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell line development? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell line development market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Reagents And Media; Equipment; Accessories And Consumables
2) By Source: Mammalian; Non-Mammalian
3) By Cell Line: Recombinant; Hybridomas; Continuous Cell Line; Primary Cell Line
4) By Application: Bioproduction; Drug Discovery; Toxicity Testing; Tissue Engineering; Research
Companies Mentioned: Thermo Fisher Scientific Inc.; Novartis AG; Danaher Corporation; Merck KGaA; GE Health Care
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18102

1. Executive Summary

2. Cell Line Development Market Characteristics

3. Cell Line Development Market Trends And Strategies

4. Cell Line Development Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Cell Line Development Market Size and Growth

5.1. Global Cell Line Development Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Cell Line Development Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cell Line Development Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell Line Development Market Segmentation

6.1. Global Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Reagents And Media
Equipment
Accessories And Consumables
6.2. Global Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Mammalian
Non-Mammalian
6.3. Global Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Recombinant
Hybridomas
Continuous Cell Line
Primary Cell Line
6.4. Global Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Bioproduction
Drug Discovery
Toxicity Testing
Tissue Engineering
Research

7. Cell Line Development Market Regional And Country Analysis

7.1. Global Cell Line Development Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cell Line Development Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell Line Development Market

8.1. Asia-Pacific Cell Line Development Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell Line Development Market

9.1. China Cell Line Development Market Overview
9.2. China Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell Line Development Market

10.1. India Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell Line Development Market

11.1. Japan Cell Line Development Market Overview
11.2. Japan Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell Line Development Market

12.1. Australia Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell Line Development Market

13.1. Indonesia Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell Line Development Market

14.1. South Korea Cell Line Development Market Overview
14.2. South Korea Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell Line Development Market

15.1. Western Europe Cell Line Development Market Overview
15.2. Western Europe Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell Line Development Market

16.1. UK Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell Line Development Market

17.1. Germany Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell Line Development Market

18.1. France Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell Line Development Market

19.1. Italy Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell Line Development Market

20.1. Spain Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell Line Development Market

21.1. Eastern Europe Cell Line Development Market Overview
21.2. Eastern Europe Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell Line Development Market

22.1. Russia Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell Line Development Market

23.1. North America Cell Line Development Market Overview
23.2. North America Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell Line Development Market

24.1. USA Cell Line Development Market Overview
24.2. USA Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell Line Development Market

25.1. Canada Cell Line Development Market Overview
25.2. Canada Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell Line Development Market

26.1. South America Cell Line Development Market Overview
26.2. South America Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell Line Development Market

27.1. Brazil Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell Line Development Market

28.1. Middle East Cell Line Development Market Overview
28.2. Middle East Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell Line Development Market

29.1. Africa Cell Line Development Market Overview
29.2. Africa Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell Line Development Market Competitive Landscape And Company Profiles

30.1. Cell Line Development Market Competitive Landscape
30.2. Cell Line Development Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Novartis AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Danaher Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck KGaA
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. GE Health Care
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Cell Line Development Market Other Major And Innovative Companies

31.1. AGC Biologics
31.2. Corning Inc.
31.3. Eurofins Scientific
31.4. Lonza Pvt. Ltd.
31.5. WuXi App tech
31.6. Sartorius AG
31.7. GenScript Biotech Corporation
31.8. FUJIFILM Diosynth Biotechnologies
31.9. Promega corporation
31.10. KBI Biopharma Inc.
31.11. Rentschler Biopharma SE
31.12. Advanced Instruments LLC
31.13. Cyagen
31.14. Horizon Discovery Group Plc
31.15. Probiogen AG

32. Global Cell Line Development Market Competitive Benchmarking

33. Global Cell Line Development Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell Line Development Market

35. Cell Line Development Market Future Outlook and Potential Analysis

35.1 Cell Line Development Market In 2028 - Countries Offering Most New Opportunities
35.2 Cell Line Development Market In 2028 - Segments Offering Most New Opportunities
35.3 Cell Line Development Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer